C 反应蛋白检测市场规模、份额、成长分析、按检测类型、按检测范围、按疾病领域、按最终用途、按地区 - 行业预测，2024-2031 年

2022 年，C 反应蛋白检测的全球市场规模为 45 亿美元，从 2023 年的 46 亿美元成长到 2031 年的 55.2 亿美元，在预测期内（2024-2031 年）预计将以年复合成长率为2.3%。

在提高特异性、敏感性和快速现场疾病诊断的奈米技术进步的推动下，全球 C 反应蛋白检测市场预计将显着成长。为了满足对快速诊断工具日益增长的需求，新的 CRP 检测即时检测方法不断出现。穆罕默德六世大学的一项研究揭示了 CRP 在评估 SARS-CoV-2 严重程度方面的潜力，进一步提升了 CRP 的重要性。此外，发炎性疾病、糖尿病、癌症盛行率的上升、子宫内膜异位症盛行率的上升以及诊断资金的增加预计将推动市场扩张。 CDC 报告称，美国有超过 2010 万成年人患有冠状动脉疾病，并且这一数字预计将继续增长。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 案例研究分析

按检测类型分類的 C 反应蛋白检测市场规模

• 市场概况
• 免疫比浊法
• 酵素连结免疫吸附试验
  • 临床
  • 非临床
• 化学冷光免疫检测
• 其他的

C反应蛋白检测市场规模：依检测范围划分

• 市场概况
• HS-CRP
• 常规CRP
• CCRP

C反应蛋白检测市场规模：依疾病领域划分

• 市场概况
• 心血管疾病
• 癌症
• 类风湿性关节炎
• 发炎性肠道疾病
• 子宫内膜异位症
• 狼疮
• 其他的

按最终用途分類的 C 反应蛋白测试市场规模

• 市场概况
• 诊所
  • 按实体分类
  • 医生办公室
  • 小诊所
  • 其他的
  • 透过设定
  • 城市氛围
  • 乡村氛围
• 医院
  • 城市氛围
  • 乡村氛围
• 研究所
  • 城市氛围
  • 乡村氛围
• 辅助生活医疗设施
  • 城市氛围
  • 乡村氛围
• 家
• 其他的

C反应蛋白检测市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Thermo Fisher Scientific Inc.
• Roche Diagnostics
• Abbott Laboratories
• Beckman Coulter
• Bio-Rad Laboratories
• Siemens Healthcare
• Quest Diagnostics
• Ortho Clinical Diagnostics
• Randox Laboratories
• Boditech Med Inc.
• Merck Millipore
• BioMerieux
• Trinity Biotech
• Becton, Dickinson and Company（BD）
• Sekisui Diagnostics
• Tosoh Bioscience Inc.
• DiaSorin SpA
• Fujifilm Corporation

结论和建议

Global C-Reactive Protein Testing Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 4.6 billion in 2023 to USD 5.52 billion by 2031, growing at a CAGR of 2.3% during the forecast period (2024-2031).

The global market for C-reactive protein testing is poised for significant growth, driven by advancements in nanotechnology that enhance specificity, sensitivity, and rapid on-site disease diagnosis. New point-of-care assays for CRP testing are emerging, responding to the increasing demand for swift diagnostic tools. Research from Mohammed VI University highlights CRP's potential in assessing SARS-CoV-2 severity, further cementing its relevance. Additionally, the rising prevalence of inflammatory disorders, diabetes, and cancers, alongside a growing incidence of endometriosis and increased funding in diagnostics, is expected to fuel market expansion. Notably, the CDC reported that over 20.1 million adults in the U.S. suffer from coronary artery disease, a number anticipated to rise, thereby amplifying market opportunities in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global C-Reactive Protein Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global C-Reactive Protein Testing Market Segmental Analysis

Global C-Reactive Protein Testing Market is segmented by assay type, detection range, disease area, end-use and region. Based on assay type, the market is segmented into immunoturbidimetric assay, ELISA, chemiluminescence immunoassay and others. Based on detection range, the market is segmented into HS-CRP, conventional CRP and cCRP. Based on disease area, the market is segmented into cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus and others. Based on end-use, the market is segmented into clinics, hospitals, laboratories, assisted living healthcare facilities, home and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global C-Reactive Protein Testing Market

The global C-reactive protein testing market is poised for significant growth, primarily fueled by the increasing prevalence of cardiovascular diseases. With over 800,000 fatalities attributed to cardiovascular conditions annually in the United States alone, the demand for effective C-reactive protein testing methods is surging. Additionally, the ongoing research and development aimed at enhancing these testing methodologies will further propel market expansion. The combination of an ageing population and a rising incidence of diabetes mellitus also contributes to this upward trend, indicating a robust market potential in the foreseeable future as healthcare providers seek better diagnostic solutions.

Restraints in the Global C-Reactive Protein Testing Market

The global C-Reactive Protein Testing market is likely to face significant restraints primarily due to low awareness about CRP testing and the limited availability of advanced technologies in lower and medium-sized economies worldwide. This lack of knowledge can lead to underutilization of these important diagnostic tools, hindering market expansion. Furthermore, the high costs associated with CRP testing procedures and the substantial initial investments required to establish appropriate setups could further inhibit growth in the market. Together, these factors pose considerable challenges that may slow down the adoption and proliferation of C-reactive protein testing solutions globally during the forecast period.

Market Trends of the Global C-Reactive Protein Testing Market

The global C-Reactive Protein (CRP) testing market is experiencing significant growth, driven by heightened awareness programs and government initiatives aimed at educating the public on chronic disease prevention and treatment. This surge in awareness has led to the widespread integration of CRP testing in routine clinical practices, particularly in developed regions such as the United States, Germany, France, and Japan. As healthcare providers increasingly prioritize CRP tests for assessing inflammation and guiding treatment decisions, the market is poised for robust expansion in the coming years, reflecting a shift towards proactive health management and early disease detection.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global C-Reactive Protein Testing Market Size by Assay Type & CAGR (2024-2031)

• Market Overview
• Immunoturbidimetric Assay
• Elisa
  • Clinical
  • Non-Clinical
• Chemiluminescence Immunoassay
• Others

Global C-Reactive Protein Testing Market Size by Detection Range & CAGR (2024-2031)

• Market Overview
• HS-CRP
• Conventional CRP
• CCRP

Global C-Reactive Protein Testing Market Size by Disease Area & CAGR (2024-2031)

• Market Overview
• Cardiovascular Diseases
• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis
• Lupus
• Others

Global C-Reactive Protein Testing Market Size by End-Use & CAGR (2024-2031)

• Market Overview
• Clinics
  • By Entity
  • Physician Offices
  • Small Clinics
  • Others
  • By Settings
  • Urban Setting
  • Rural Setting
• Hospitals
  • Urban Setting
  • Rural Setting
• Laboratories
  • Urban Setting
  • Rural Setting
• Assisted Living Healthcare Facilities
  • Urban Setting
  • Rural Setting
• Home
• Others

Global C-Reactive Protein Testing Market Size & CAGR (2024-2031)

• North America (Assay Type, Detection Range, Disease Area, End-Use)
  • US
  • Canada
• Europe (Assay Type, Detection Range, Disease Area, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Assay Type, Detection Range, Disease Area, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Assay Type, Detection Range, Disease Area, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Assay Type, Detection Range, Disease Area, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boditech Med Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Millipore
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Bioscience Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations